GlaxoSmithKline hunts agency to promote weight-loss drug in Europe
By Kunal Dutta, campaignlive.co.uk, Friday, 16 November 2007 12:00AM
GlaxoSmithKline has kicked off a search for Alli - a US over-the-counter weight-loss drug - as it looks to launch the product across Europe.
GSK has approached a number of London agencies, with both roster and non-roster agencies being asked to tender.
The brief comprises digital and DM elements. Much of the initial work will be adapted from US advertising until such time as plans to launch the drug in Europe are given the go-ahead.
GlaxoSmithKline has already made inroads to get the product approved for sale in Europe, though under a different name. Last month, the European medicines regulator agreed to review a proposal for the drug's over- the-counter sale and respond next year.
This summer, Alli became the first weight-loss drug approved by the United States' Food and Drug Administration for sale over the counter. In the first five weeks after its launch, sales were more than £77 million.
GlaxoSmithKline did not return calls.
This article was first published on campaignlive.co.uk
- Senior Digital Designer Twist Recruitment £35000 - £42000 per annum + benefits, City of London
- Digital Marketing Manager Online Resourcing Attractive salary and benefits, Leeds, West Yorkshire
- Account Manager > ATL > INDEPENDENT AGENCY collectivo Up to £30,000 per annum, West London
- Graphic Designer Nu Creative Talent £35000.00 - £45000.00 per annum, London
- Web Designer Nu Creative Talent £35000.00 - £40000.00 per annum, Manchester
- Group M wins Vodafone's £600m media account
- Google becomes major UK advertiser after boosting spend by 50% in 2013
- Campaign Viral Chart: Evian's Spider-Man tops chart in week of movie premiere
- Unilever pilots multi-brand advertising with YouTube beauty channel
- MEC boss Courtier hails £600m Vodafone media win as 'life changing'
- 'We will always love M&S' says Walker Media in goodbye statement